Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Predicting Treatment Response in Social Anxiety Disorder From Functional MRI
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psychiatry In Depth
Page 1 of 1
Predicting Treatment Response in Social Anxiety Disorder From Functional MRI
Predicting Treatment Response in Social Anxiety Disorder From Functional MRI
Source: JAMA Psychiatry. 2013;70(1):87-97
Current behavioral measures poorly predict treatment outcome in social anxiety disorder (SAD). To our knowledge, this is the first study to examine neuroimaging-based treatment prediction in SAD.
Objective: To measure brain activation in patients with SAD as a biomarker to predict subsequent response to cognitive behavioral therapy (CBT).
Design: Functional magnetic resonance imaging (fMRI) data were collected prior to CBT intervention. Changes in clinical status were regressed on brain responses and tested for selectivity for social stimuli.
Patients: 39 medication-free patients meeting DSM-IV criteria for the generalized subtype of SAD.
Interventions: Brain responses to angry vs neutral faces or emotional vs neutral scenes were examined with fMRI prior to initiation of CBT.
Results:
- Pretreatment responses significantly predicted subsequent treatment outcome of patients selectively for social stimuli and particularly in regions of higher-order visual cortex.
- Combining the brain measures with information on clinical severity accounted for more than 40% of the variance in treatment response and substantially exceeded predictions based on clinical measures at baseline.
- Prediction success was unaffected by testing for potential confounding factors such as depression severity at baseline.
Conclusions:
- The results suggest that brain imaging can provide biomarkers that substantially improve predictions for the success of cognitive behavioral interventions and more generally suggest that such biomarkers may offer evidence-based, personalized medicine approaches for optimally selecting among treatment options for a patient.
Similar topics
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
» Hallucinogen Psilocybin (Active ingredient in Magic Mushrooms): Potential Role in Treatment of Depression, Anxiety & possibly Cluster Headaches.
» Serotonin States and Social Anxiety.
» Anxiety Disorder: Overview & Facts
» FDA approves first generic Lexapro to treat depression and anxiety disorder
» Hallucinogen Psilocybin (Active ingredient in Magic Mushrooms): Potential Role in Treatment of Depression, Anxiety & possibly Cluster Headaches.
» Serotonin States and Social Anxiety.
» Anxiety Disorder: Overview & Facts
» FDA approves first generic Lexapro to treat depression and anxiety disorder
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psychiatry In Depth
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin